DF/HCC Program Affiliation

Leukemia
Outcomes Research

Research Abstract

My research focuses on health services and outcomes for patients with cancer. I am most interested in these as they relate to patients with hematologic malignancies. Specific projects include understanding how cancer care is marketed (with a focus on direct-to-consumer advertising of hematology and oncology medications), epidemiology of genetic markers in patients with myeloproliferative disease and thrombosis, outcomes for hematologic malignancies in large databases such as the Nurse’s Health Study, and understanding referral patterns/delays in diagnosis for patients with hematologic malignancies.

Publications

• Abel GA, Deangelo DJ, Connors JM, Sholl LM, McCaffrey RP, Longtine JA.Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations.Am J Hematol 2008 Jan 29.
  18306358
• Abel GA, Lee SJ, Weeks JC.Direct-to-consumer advertising in oncology: a content analysis of print media.J Clin Oncol 2007 Apr 1;25(10):1267-71.
  17401016
• Abel GA, Penson RT, Joffe S, Schapira L, Chabner BA, Lynch TJ.Direct-to-consumer advertising in oncology.Oncologist 2006 Feb;11(2):217-26.
  16476842
• Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA.Effects of biochemically confirmed smoking cessation on white blood cell count.Mayo Clin Proc 2005 Aug;80(8):1022-8.
  16092581